{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "A shift by the federal government in how it pays for drugs for dialysis patients may have had an unintended and potentially dire consequence, researchers say.", "headline": {"seo": "Dialysis Rule Changes Followed by Transfusion Increases", "main": "Unintended Consequence for Dialysis Patients as Drug Rule Changes", "print_headline": "Unintended Consequence for Dialysis Patients as Drug Rule Changes"}, "abstract": "Research by the United States Renal Data System finds that a shift in the Medicare reimbursement policy for drugs to treat dialysis patients has caused a significant jump in the rate of blood transfusions; more frequent transfusions put dialysis patients at a greater risk for organ transplant failure.", "print_page": "24", "word_count": "1034", "_id": "515b5a20fdc59278db008a92", "snippet": "A shift by the federal government in how it pays for drugs for dialysis patients may have had an unintended and potentially dire consequence, researchers say.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/05/11/health/policy/dialysis-rule-changes-followed-by-transfusion-increases.html", "multimedia": [{"subtype": "xlarge", "url": "images/2012/05/11/us/TRANSFUSION/TRANSFUSION-articleLarge.jpg", "height": 316, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2012/05/11/us/TRANSFUSION/TRANSFUSION-articleLarge.jpg", "xlargeheight": "316"}, "type": "image"}], "subsection_name": "Money & Policy", "keywords": [{"value": "Dialysis", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Transfusions", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Medicare", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Kidneys", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Anemia", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Kevin", "lastname": "SACK"}], "original": "By KEVIN SACK"}, "document_type": "article", "pub_date": "2012-05-11T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "Polish judicial professionals concluded that the conservative drug law wasn't effective in fighting the drug trade.", "headline": {"main": "Saying No to Costly Drug Laws", "kicker": "Op-Ed Contributor", "print_headline": "Saying No to Costly Drug Laws", "content_kicker": "Op-Ed Contributor"}, "abstract": null, "print_page": "", "word_count": "879", "_id": "53f6996e798810309f422430", "snippet": "Polish judicial professionals concluded that the conservative drug law wasn't effective in fighting the drug trade.", "source": "International Herald Tribune", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/05/11/opinion/saying-no-to-costly-drug-laws.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Poland", "is_major": "N", "rank": "2", "name": "glocations"}, {"value": "Law and Legislation", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Aleksander", "lastname": "KWASNIEWSKI"}], "original": "By ALEKSANDER KWASNIEWSKI"}, "document_type": "article", "pub_date": "2012-05-11T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "An Endless Quest for Weight-Loss Pills ", "kicker": "well"}, "abstract": "The weight-loss field is strewn with lemons, more so than other areas of medicine, and because of the enormous potential market for these drugs, pharmaceutical companies rush new drugs to market after conducting only small clinical trials, writes Dr. Danielle Ofri.", "print_page": null, "word_count": "1004", "_id": "4fd3a45c8eb7c8105d8eedaf", "snippet": "The weight-loss field is strewn with lemons, more so than other areas of medicine, and because of the enormous potential market for these drugs, pharmaceutical companies rush new drugs to market after conducting only small clinical trials, writes Dr....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2012/05/10/an-endless-quest-for-weight-loss-pills/", "multimedia": [{"subtype": "wide", "url": "images/2012/05/09/health/Danielle-Ofri/Danielle-Ofri-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2012/05/09/health/Danielle-Ofri/Danielle-Ofri-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/05/09/health/Danielle-Ofri/Danielle-Ofri-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/05/09/health/Danielle-Ofri/Danielle-Ofri-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Doctors", "name": "subject", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "Fen-Phen (Drug Combination)", "name": "subject", "rank": "3"}, {"value": "Medicine and Health", "name": "subject", "rank": "4"}, {"value": "Obesity", "name": "subject", "rank": "5"}, {"value": "Qnexa (Drug)", "name": "subject", "rank": "6"}, {"value": "Weight", "name": "subject", "rank": "7"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Danielle", "lastname": "OFRI", "rank": 1, "role": "reported", "organization": ""}], "original": "By DANIELLE OFRI, M.D"}, "document_type": "blogpost", "pub_date": "2012-05-10T12:54:49Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "", "headline": {"main": "Should Churches Get Tax Breaks?", "kicker": "Room For Debate"}, "abstract": "Should religious organizations be subject to the same rules and taxes as secular ones?", "print_page": null, "word_count": "2257", "_id": "54f1f2b379881073aef9ec60", "snippet": "Should religious organizations be subject to the same rules and taxes as secular ones?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/roomfordebate/2012/05/09/should-churches-get-tax-breaks/", "multimedia": [], "subsection_name": "Room For Debate", "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2012-05-09T19:49:24Z", "section_name": "Opinion"}], "meta": {"hits": 4, "offset": 0, "time": 46}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}